Add to ORKGCurrently, biological agents are used worldwide particularly in the treatment of severe psoriasis. Nevertheless dermatologists still have limited clinical experience with these promising new treatments. Biological agents should only be used in a systematic and controlled manner since they are relatively expensive, with insufficient data about their long-term efficacy and toxicity. Therefore, several countries developed national guidelines for use of biological agents in psoriasis, considering the evidence-based literature data and personal views of clinical experts. Our review's purpose is to emphasize the commonalities and differences of these guidelines. (Turkderm 2008; 42 Suppl 2: 60-5
Psoriasis is a complex and chronic disease, and, in most cases, therapies are required during all pa...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Background Psoriasis is a chronic, inflammatory skin disorder that has a significant impact on quali...
The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized...
Item does not contain fulltextPsoriasis is a chronic, immune-mediated disorder that usually requires...
The advent of biologic agents within the past two decades has dramatically improved the treatment of...
Psoriasis is a common, persistent, relapsing inflammatory skin disease that can be associated with ...
In the management of moderate-to-severe psoriasis, increasingly complex clinical scenarios necessita...
Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythema...
Abstract Background: In the management of moderate-to-severe psoriasis, increasingly complex clinica...
Psoriasis is a chronic, immune-mediated disorder that usually requires long-term treatment for contr...
The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic...
We are pleased that the British Association of Dermatologists guidelines on use of biological therap...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis is a complex and chronic disease, and, in most cases, therapies are required during all pa...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Background Psoriasis is a chronic, inflammatory skin disorder that has a significant impact on quali...
The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized...
Item does not contain fulltextPsoriasis is a chronic, immune-mediated disorder that usually requires...
The advent of biologic agents within the past two decades has dramatically improved the treatment of...
Psoriasis is a common, persistent, relapsing inflammatory skin disease that can be associated with ...
In the management of moderate-to-severe psoriasis, increasingly complex clinical scenarios necessita...
Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythema...
Abstract Background: In the management of moderate-to-severe psoriasis, increasingly complex clinica...
Psoriasis is a chronic, immune-mediated disorder that usually requires long-term treatment for contr...
The overall aim of the guideline is to provide evidence-based recommendations on the use of biologic...
We are pleased that the British Association of Dermatologists guidelines on use of biological therap...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis is a complex and chronic disease, and, in most cases, therapies are required during all pa...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Background Psoriasis is a chronic, inflammatory skin disorder that has a significant impact on quali...